Literature DB >> 12360438

Risk factors associated with the development of skin cancer after liver transplantation.

Abigail B Mithoefer1, Stacey Supran, Richard B Freeman.   

Abstract

Skin cancer is a well-recognized long-term complication of transplantation and immunosuppression. Although risk factors for the development of skin cancer in the general population are well defined, risk factors for the development of these lesions have not been identified clearly in the liver transplant population. We surveyed 151 liver transplant (LTx) recipients for risk factors associated with cutaneous malignancies in the general population. Variables included were: demographics, primary liver disease, severity of disease at LTx, immunosuppression history, complexion, hair color, eye color, tanning profile, number of moles, occupational history, sun exposure history, sunburn history, family history of skin cancer, and any history of removed skin lesions. All skin cancers were confirmed histologically. There were 86 documented skin cancers in 34 patients: 56 squamous cell, 23 basal cell and 7 melanomas. Median follow-up was 1490 days. In a univariate analysis, age, male gender, red hair, brown eyes, primary sclerosing cholangitis (PSC), primary biliary cirrhosis (protective), cyclosporine, number of second degree sunburns, and frequent lifetime sun exposure were associated with the development of new skin cancers. In a multivariate model, age, male gender, red hair, brown eyes, PSC, and cyclosporine remain the strongest predictors. The incidence of skin cancer after liver transplantation is underestimated. In particular, there is a higher incidence of squamous cell carcinoma compared with the general population. Recipients with identified risk factors may be candidates for prophylactic treatment and should be followed more intensively after liver transplantation.

Entities:  

Mesh:

Year:  2002        PMID: 12360438     DOI: 10.1053/jlts.2002.35551

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  18 in total

Review 1.  Solid, non-skin, post-liver transplant tumors: Key role of lifestyle and immunosuppression management.

Authors:  Christophe Carenco; Stéphanie Faure; José Ursic-Bedoya; Astrid Herrero; Georges Philippe Pageaux
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 2.  De novo hepatocellular carcinoma occurring in a transplanted liver: case report and review of the literature.

Authors:  Anca Croitoru; Thomas D Schiano; Myron Schwartz; Sasan Roayaie; Ruliang Xu; Arief Suriawinata; M Isabel Fiel
Journal:  Dig Dis Sci       Date:  2006-10       Impact factor: 3.199

3.  Evolution and management of de novo neoplasm post-liver transplantation: a 20-year experience from a single European centre.

Authors:  Gonzalo Sapisochin; Itxarone Bilbao; Cristina Dopazo; Luis Castells; Jose Luis Lázaro; Roberto Rodríguez; Mireia Caralt; Laia Blanco; Joaquin Balsells; Ramón Charco
Journal:  Hepatol Int       Date:  2010-12-28       Impact factor: 6.047

4.  Decision tree analysis to stratify risk of de novo non-melanoma skin cancer following liver transplantation.

Authors:  Tomohiro Tanaka; Michael D Voigt
Journal:  J Cancer Res Clin Oncol       Date:  2018-01-23       Impact factor: 4.553

5.  Skin Cancer-Sun Knowledge and Sun Protection Behaviors of Liver Transplant Recipients in Turkey.

Authors:  Meryem Ozturk Haney; Yaprak Sarigol Ordin; Gulcihan Arkan
Journal:  J Cancer Educ       Date:  2019-02       Impact factor: 2.037

6.  Skin cancer in immunosuppressed transplant patients: Vigilance matters.

Authors:  Ozan Unlu; Emir Charles Roach; Alexis Okoh; May Olayan; Bulent Yilmaz; Didem Uzunaslan; Abdullah Shatnawei
Journal:  World J Hepatol       Date:  2015-04-08

Review 7.  Incidence, risk factors and outcomes of de novo malignancies post liver transplantation.

Authors:  Pavan Kedar Mukthinuthalapati; Raghavender Gotur; Marwan Ghabril
Journal:  World J Hepatol       Date:  2016-04-28

8.  Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence.

Authors:  John H Kempen; Sapna Gangaputra; Ebenezer Daniel; Grace A Levy-Clarke; Robert B Nussenblatt; James T Rosenbaum; Eric B Suhler; Jennifer E Thorne; C Stephen Foster; Douglas A Jabs; Kathy J Helzlsouer
Journal:  Am J Ophthalmol       Date:  2008-06-25       Impact factor: 5.258

9.  Squamous cell carcinoma in solid organ transplant recipients: influences on perception of risk and optimal time to provide education.

Authors:  Nikki N Kim; Susan L Boone; Sara Ortiz; Kim Mallett; Jerod Stapleton; Rob Turrisi; Simon Yoo; Dennis P West; Alfred W Rademaker; June K Robinson
Journal:  Arch Dermatol       Date:  2009-10

Review 10.  Donor transmitted and de novo cancer after liver transplantation.

Authors:  Rajeev Desai; James Neuberger
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.